Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
Emerging Adulthood01:27

Emerging Adulthood

661
Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
661
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

289
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
289
Fixed Action Patterns01:06

Fixed Action Patterns

17.6K
A fixed action pattern (FAP) is a specific, hard-wired sequence of behaviors that occurs in response to an external stimulus, called a sign stimulus. The behavior is “fixed” because it is essentially unchangeable—proceeding similarly across individuals of a species every time it occurs.
17.6K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

232
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
232
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

5.5K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolically healthy obesity is independently associated with 20-year incidence of cardiovascular disease: findings from the ATTICA cohort study (2002-2022).

International journal of obesity (2005)·2026
Same author

[Diagnosis and treatment of thyroid dysfunction associated with amiodarone].

Deutsche medizinische Wochenschrift (1946)·2026
Same author

One-Hour Post-Load Glucose Is Associated with Multisystem Complications in People Living with Obesity.

Biomolecules·2026
Same author

Neuromuscular Scoliosis as a Rare Manifestation of Guillain-Barré Syndrome in a Child.

Cureus·2026
Same author

Revision of total elbow arthroplasty due to humeral loosening with large bone defect using humeral allograft-prosthesis composite: A case report.

International journal of surgery case reports·2025
Same author

HDL cholesterol as an associate of prevalent coronary artery disease in heterozygous Familial hypercholesterolemia beyond LDL cholesterol.

Endocrine·2025

Related Experiment Video

Updated: Jan 27, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.7K

Emerging Fixed-Dose Combination Treatments for Hyperlipidemia.

Eleni Pappa1, Christos V Rizos1, Theodosios D Filippatos2

  • 11 Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, Greece.

Journal of Cardiovascular Pharmacology and Therapeutics
|March 27, 2019
PubMed
Summary

Fixed-dose drug combinations offer improved lipid management for high-risk patients. Combining statins with other hypolipidemic agents enhances efficacy and adherence, potentially improving cardiovascular outcomes.

Keywords:
atorvastatinbembedoic acidberberineezetimibefenofibratefixed-dose drug combinationshydroxychloroquinehyperlipidemiarosuvastatin

More Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.8K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

2.0K

Related Experiment Videos

Last Updated: Jan 27, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.7K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.8K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

2.0K

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Metabolic Diseases

Background:

  • Statin monotherapy often fails to achieve low-density lipoprotein cholesterol targets, particularly in high-risk individuals.
  • Atherogenic dyslipidemia presents a challenge in specific patient subgroups, necessitating alternative treatment strategies.
  • Combination therapy with hypolipidemic drugs may offer synergistic benefits over monotherapy.

Purpose of the Study:

  • To review novel fixed-dose drug combinations for hyperlipidemia management.
  • To highlight the efficacy and safety of combining established hypolipidemic agents.
  • To explore the potential of emerging hypolipidemic drugs in combination therapy.

Main Methods:

  • Literature review of clinical trials and pharmacological data.
  • Analysis of established hypolipidemic drug classes: statins, ezetimibe, and fibrates.
  • Inclusion of emerging agents like bempedoic acid and berberine.

Main Results:

  • Combination therapy with statins, ezetimibe, and fibrates demonstrates enhanced lipid-lowering efficacy and safety.
  • Fixed-dose formulations improve patient adherence to hypolipidemic treatment regimens.
  • Combined therapies may offer additional benefits, including improved carbohydrate metabolism.

Conclusions:

  • Fixed-dose combinations of hypolipidemic agents provide an effective and safe strategy for managing hypercholesterolemia.
  • These combinations address unmet needs in patients resistant to monotherapy or with complex lipid profiles.
  • Novel fixed-dose combinations represent a promising advancement in cardiovascular risk reduction.